Posts by: Margarida Azevedo

Margarida Azevedo

Margarida graduated with a BS in Health Sciences from the University of Lisbon and a MSc in Biotechnology from Instituto Superior Técnico (IST-UL). She worked as a molecular biologist research associate at a Cambridge UK-based biotech company that discovers and develops therapeutic, fully human monoclonal antibodies.

April 13, 2016April 13, 2016

Genentech’s Atezolizumab for Non-Small Cell Lung Cancer Gets FDA Nod for BLA and Priority Review

Lung Cancer, News

The U.S. Food and Drug Administration (FDA) has accepted Genentech’s Biologics License Application (BLA) and granted Priority Review for the company’s product atezolizumab for the treatment of locally advanced or ... Read more

April 11, 2016April 11, 2016

Segmental Vapor Ablation for Emphysema Improves Patients’ Pulmonary Function, Researchers Find

Emphysema, News

In a new study, researchers investigated whether selective treatment with vapor ablation of the more diseased lobe segments in the lungs led to clinical improvements in patients suffering from severe ... Read more

April 7, 2016April 7, 2016

Study of Roflumilast for COPD Confirms Benefits as Alternative Therapy

COPD, News

Researchers at Sichuan University in China conducted a study to clarify the controversial therapeutic effects of roflumilast in patients with moderate-to-severe chronic obstructive pulmonary disease (COPD). The team found that roflumilast led ... Read more

April 6, 2016April 6, 2016

Arch Biopartners Licenses Drug Candidate to Treat CF Lung Infections

Cystic Fibrosis, News

Arch Biopartners, Inc., recently announced that it has entered an exclusive license agreement with the University of Cincinnati (UC) for commercial rights to UC’s AB569, a drug candidate for the ... Read more

April 5, 2016April 5, 2016

In Infants with Bronchiolitis, Study Points to Need for Re-evaluation of Clinical Care, Diagnostic Tools

Bronchiolitis, News

In a new study, researchers at The Hospital for Sick Children (SickKids) in Toronto, Canada, analyzed the suitability of pulse oximetry as a decision-making tool in bronchiolitis, and concluded that ... Read more

April 1, 2016April 4, 2016

Two Lives Saved as Stanford Health Team Performs Rare Domino Transplant

Cystic Fibrosis, News

A surgical team at Stanford Health Care, under the leadership of heart surgeon Dr. Joseph Woo, has performed a rare “domino” transplant, saving the lives of two women. The technique has ... Read more

March 31, 2016April 4, 2016

For Preschoolers with Cystic Fibrosis, Clinicians Develop New Guidelines, Clinical Care Recommendations

Cystic Fibrosis, News

A multidisciplinary team of clinicians and researchers created a comprehensive document featuring guidelines and recommendations for the clinical care of preschool children between the ages of 2 and 5 who have ... Read more

March 28, 2016March 28, 2016

Boehringer Ingelheim Enrolls 1st Patient in ‘Real World’ Study of Pradaxa for Deep Vein Thrombosis and PE

News, Pulmonary embolism

Boehringer Ingelheim pharmaceutical company recently announced the launch and enrollment of the first patient in its RE-COVERY DVT/PE global observational study, which will eventually include 14,000 patients globally and collect data on ... Read more

March 24, 2016March 24, 2016

Researchers Build Promising CF Diagnostic System Using Microsoft’s Xbox Kinect Sensors

Cystic Fibrosis, News

In a new study, researchers describe the development of a low-cost and effective chest wall motion assessment system, essential for the rapid and accurate diagnosis of respiratory diseases, that uses ... Read more

March 22, 2016March 22, 2016

Xalkori (Crizotinib), for Certain Non-Small Cell Lung Cancers, Gets FDA New Drug Application Approval

Lung Cancer, News

Pfizer’s supplemental new drug application for Xalkori (crizotinib) has been approved by the U.S. FDA for the treatment of patients with ROS1-positive metastatic non-small cell lung cancer (NSCLC). The drug is also ... Read more